Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fractional Shares

1,439.11
+22.801.61%
Number of Gainers:903
Number of Losers:123
Number of Flat:12
PE:- -
High:1,442.62
Open:1,416.42
Low:1,416.42
Close:1,416.31
Loading ...

Lumen Technologies Q1 Revenue $3.18 Bln VS Ibes Estimate of $3.12 Bln

THOMSON REUTERS
·
Yesterday

Lumen Technologies: Reiterated Full-Year 2025 Financial Outlook

THOMSON REUTERS
·
Yesterday

Lumen Technologies Q1 Adjusted Free Cash Flow USD 354 Million

THOMSON REUTERS
·
Yesterday

Strategy: Increasing 2025 "BTC Yield" Target From 15% to 25%

THOMSON REUTERS
·
Yesterday

Strategy: Announces a New $21 Bln at--Market (Atm) Common Stock Equity Offering

THOMSON REUTERS
·
Yesterday

Microstrategy Q1 Revenue USD 111.066 Million VS. Ibes Estimate USD 115.8 Million

THOMSON REUTERS
·
Yesterday

Strategy: 553,555 Bitcoin Holdings at a Total Cost of $37.90 Billio as of April 28, 2025

THOMSON REUTERS
·
Yesterday

Hologic Announces Financial Results for Second Quarter of Fiscal 2025

THOMSON REUTERS
·
Yesterday

Hologic Q2 Adjusted Operating Margin 30%

THOMSON REUTERS
·
Yesterday

Hologic Outlook FY EPS USD 2.47-2.57

THOMSON REUTERS
·
Yesterday

Hologic Q2 Adjusted Ebitda USD 325.8 Million VS. Ibes Estimate USD 324.7 Million

THOMSON REUTERS
·
Yesterday

Hologic Inc - Company Maintains Annual Revenue Guidance, Lowers Guidance for Gaap and Non-Gaap EPS

THOMSON REUTERS
·
Yesterday

Hologic Q2 Adjusted Gross Margin 61.1%

THOMSON REUTERS
·
Yesterday

Duolingo Adds Record Number of Daus, Surpasses 10 Million Paid Subscribers, and Reports 38% Year-Over-Year Revenue Growth in First Quarter 2025

THOMSON REUTERS
·
Yesterday

Amgen Q1 Adj EPS $4.90 VS Ibes Estimate $4.30

THOMSON REUTERS
·
Yesterday

Amgen Outlook FY Adj EPS $20.00 to $21.20 VS Ibes Estimate $20.64

THOMSON REUTERS
·
Yesterday

Press Release: Viper Energy, Inc. Announces Closing of Drop Down Transaction

Dow Jones
·
Yesterday

Press Release: Ascendis Pharma Reports First Quarter 2025 Financial Results

Dow Jones
·
Yesterday

Amgen: Phase 1 Study of Amg 513 Enrolling People Living With Obesity After Removal of Clinical Hold by U.S. FDA

THOMSON REUTERS
·
Yesterday

Amgen: 2025 Outlook Includes Estimated Impact of Implemented Tariffs, but Does Not Account for Any Future Levies

THOMSON REUTERS
·
Yesterday